337 related articles for article (PubMed ID: 26246573)
1. Hydrodynamic and Membrane Binding Properties of Purified Rous Sarcoma Virus Gag Protein.
Dick RA; Datta SA; Nanda H; Fang X; Wen Y; Barros M; Wang YX; Rein A; Vogt VM
J Virol; 2015 Oct; 89(20):10371-82. PubMed ID: 26246573
[TBL] [Abstract][Full Text] [Related]
2. The Structure of Immature Virus-Like Rous Sarcoma Virus Gag Particles Reveals a Structural Role for the p10 Domain in Assembly.
Schur FK; Dick RA; Hagen WJ; Vogt VM; Briggs JA
J Virol; 2015 Oct; 89(20):10294-302. PubMed ID: 26223638
[TBL] [Abstract][Full Text] [Related]
3. Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.
Dick RA; Kamynina E; Vogt VM
J Virol; 2013 Dec; 87(24):13598-608. PubMed ID: 24109216
[TBL] [Abstract][Full Text] [Related]
4. Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.
Dick RA; Barros M; Jin D; Lösche M; Vogt VM
J Virol; 2015 Dec; 90(5):2473-85. PubMed ID: 26676779
[TBL] [Abstract][Full Text] [Related]
5. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
[TBL] [Abstract][Full Text] [Related]
6. Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.
Inlora J; Collins DR; Trubin ME; Chung JY; Ono A
mBio; 2014 Dec; 5(6):e02202. PubMed ID: 25491356
[TBL] [Abstract][Full Text] [Related]
7. Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.
Chan J; Dick RA; Vogt VM
J Virol; 2011 Oct; 85(20):10851-60. PubMed ID: 21813603
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-(4,5)-Bisphosphate Acyl Chains Differentiate Membrane Binding of HIV-1 Gag from That of the Phospholipase Cδ1 Pleckstrin Homology Domain.
Olety B; Veatch SL; Ono A
J Virol; 2015 Aug; 89(15):7861-73. PubMed ID: 25995263
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
[TBL] [Abstract][Full Text] [Related]
10. Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.
Heyrana KJ; Goh BC; Perilla JR; Nguyen TN; England MR; Bewley MC; Schulten K; Craven RC
J Virol; 2016 Jun; 90(12):5700-5714. PubMed ID: 27053549
[TBL] [Abstract][Full Text] [Related]
11. Effects of Membrane Charge and Order on Membrane Binding of the Retroviral Structural Protein Gag.
Wen Y; Dick RA; Feigenson GW; Vogt VM
J Virol; 2016 Oct; 90(20):9518-32. PubMed ID: 27512076
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol Promotes Protein Binding by Affecting Membrane Electrostatics and Solvation Properties.
Doktorova M; Heberle FA; Kingston RL; Khelashvili G; Cuendet MA; Wen Y; Katsaras J; Feigenson GW; Vogt VM; Dick RA
Biophys J; 2017 Nov; 113(9):2004-2015. PubMed ID: 29117524
[TBL] [Abstract][Full Text] [Related]
13. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.
Campbell S; Vogt VM
J Virol; 1997 Jun; 71(6):4425-35. PubMed ID: 9151833
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
Keller PW; Johnson MC; Vogt VM
J Virol; 2008 Jul; 82(14):6788-97. PubMed ID: 18448521
[TBL] [Abstract][Full Text] [Related]
15. Atomic Modeling of an Immature Retroviral Lattice Using Molecular Dynamics and Mutagenesis.
Goh BC; Perilla JR; England MR; Heyrana KJ; Craven RC; Schulten K
Structure; 2015 Aug; 23(8):1414-1425. PubMed ID: 26118533
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 Gag-membrane interactions by specific RNAs.
Todd GC; Duchon A; Inlora J; Olson ED; Musier-Forsyth K; Ono A
RNA; 2017 Mar; 23(3):395-405. PubMed ID: 27932583
[TBL] [Abstract][Full Text] [Related]
17. Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.
Joshi SM; Vogt VM
J Virol; 2000 Nov; 74(21):10260-8. PubMed ID: 11024160
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 matrix-31 membrane binding peptide interacts differently with membranes containing PS vs. PI(4,5)P
O'Neil L; Andenoro K; Pagano I; Carroll L; Langer L; Dell Z; Perera D; Treece BW; Heinrich F; Lösche M; Nagle JF; Tristram-Nagle S
Biochim Biophys Acta; 2016 Dec; 1858(12):3071-3081. PubMed ID: 27641491
[TBL] [Abstract][Full Text] [Related]
19. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain.
Dalton AK; Ako-Adjei D; Murray PS; Murray D; Vogt VM
J Virol; 2007 Jun; 81(12):6434-45. PubMed ID: 17392361
[TBL] [Abstract][Full Text] [Related]
20. Multimerizable HIV Gag derivative binds to the liquid-disordered phase in model membranes.
Keller H; Kräusslich HG; Schwille P
Cell Microbiol; 2013 Feb; 15(2):237-47. PubMed ID: 23121220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
